Loading clinical trials...
Loading clinical trials...
The purpose of the study is to expand the understanding of the safety profile of 13vPnC in routine use following licensure and introduction of the vaccine.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Pfizer
Collaborators
NCT07205289 · Pneumococcal Disease, Invasive, Pneumococcal Disease
NCT06731374 · Pneumococcal Disease, Pneumococcal Carriage
NCT06044077 · Pneumococcal Disease
NCT06790290 · Pneumococcal Disease, Invasive
NCT05569954 · Pneumococcal Disease
Northern California Kaiser Permanente
Oakland, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions